Merck Research Laboratories
630 and 650 Gateway Boulevard
South San Francisco
California
94080
United States
Tel: 650-496-4630
About Merck Research Laboratories
Merck Research Laboratories (MRL), the arm of our company focused on discovering and developing therapies to improve patients’ lives, is expanding its discovery capabilities in South San Francisco by breaking ground on a new, cutting-edge research facility, scheduled to be operational in 2019. Construction began in 2017 on the new South San Francisco site, which will build upon Merck’s established Bay Area presence while strengthening our discovery research capabilities.
17 articles about Merck Research Laboratories
-
Merck's Keytruda won FDA approval for the treatment of patients with high-risk, early-stage triple-negative breast cancer. The approval marked the 30th for Keytruda.
-
Roger Perlmutter, the former president of Merck Research Laboratories, will helm drug discovery startup Eikon Therapeutics, Inc.
-
BioSpace Movers and Shakers for Oct. 15
10/15/2018
Who mixed things up in the biotech world this past week? Pfizer announces its leadership team, Rheos gets a new COO, and board of directors updates from multiple biopharma companies. -
Merck Research Laboratories Facilities Designated As “Milestones In Microbiology” Sites By The American Society For Microbiology
10/18/2016
-
Merck & Co., Inc. Announces Appointment of Roger M. Perlmutter, M.D., Ph.D., as President of Merck Research Laboratories; Peter S. Kim, Ph.D., to Retire
3/7/2013
-
Genome Institute of Singapore Scientists, in Collaboration With the Industry, Unravels Mechanism That Causes Liver Cancer
5/29/2012
-
New Method Finds Networks Of Genes Behind Obesity, Merck Research Laboratories Study
3/17/2008
-
BioSpace, BioNJ and Pennsylvania Bio Welcome Over 800 Life Science Career Candidates to Biotech 2007 Career Fair
10/31/2007
-
Dr. Luciano Rossetti, Internationally-Recognized Physician And Researcher, Joins Merck Research Laboratories In Key Leadership Role; Will Focus On Developing New Treatments For Diabetes And Obesity, Two Growing Global Health Problems
8/16/2006
-
Dr. John F. Reilly Of Merck Research Laboratories Boston To Speak At International Business Communications' 11th Annual Drug Discovery Technology(R) & Development World Congress
8/7/2006
-
10 Voters On Panel Backing Pain Pills Had Industry Ties
2/25/2005
-
Drug-Ad Limits Could Spread
2/22/2005
-
Germany To Restrict Use Of Cox-2 Inhibitors
2/21/2005
-
FDA Panel Seeks Ban On Some Cox-2 Ads
2/21/2005
-
The Naproxen Risk That Wasn't
2/18/2005
-
For FDA Panel, Big Question Is Why?
2/18/2005
-
Companies Debate Arthritis Drug Safety At FDA; Whistleblower To Air New Pain Drug Analysis
2/17/2005